Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-26 @ 1:04 AM
Study NCT ID:
NCT00832260
Status:
COMPLETED
Last Update Posted:
2019-02-20
First Post:
2009-01-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
IES-ACap: Influence of Atrial Pulse Width in the Behaviour of ACap™ Confirm Algorithm.
Sponsor:
Abbott Medical Devices
Organization:
Study Overview
Official Title:
Influence of Atrial Pulse Width in the Behaviour of ACap™ Confirm Algorithm.
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IES-ACap
Brief Summary:
The purpose of this observational study is to collect data regarding the population of patients with a pacemaker implanted.
Detailed Description:
The purpose of this observational study is to collect data regarding the population of patients whit a Zephyr™ pacemaker implanted, models 5826 and 5820, and active or passive fixation leads , when the Algorithms Acap Confirm, which automatically regulates the Atrial Pulse Width, is enabled.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: